ArticleRegenerative therapy2022

CRISPR/Cas9 and AAV mediated insertion of β2 microglobulin-HLA-G fusion gene protects mesenchymal stromal cells from allogeneic rejection and potentiates the use for off-the-shelf cell therapy.

Sohsuke Meshitsuka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.